Literature DB >> 4202207

Distribution of trimethoprim-sulfamethoxazole in tissues of rhesus monkeys.

W A Craig, C M Kunin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4202207     DOI： 10.1093/infdis/128.supplement_3.s575

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

1.  Low trimethoprim susceptibility of anaerobic bacteria due to insensitive dihydrofolate reductases.

Authors:  R L Then; P Angehrn
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

2.  The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects.

Authors:  M W Hruska; J A Amico; T Y Langaee; R E Ferrell; S M Fitzgerald; R F Frye
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

3.  Intrarenal distribution of trimethoprim and sulfamethoxazole.

Authors:  S Trottier; M G Bergeron; C Lessard
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

4.  Comparative concentrations of cefoxitin in human lungs and sera.

Authors:  E J Perea; M C Garcia-Iglesias; J Ayarra; J Loscertales
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

Review 5.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

6.  HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo.

Authors:  Charlotte V Hobbs; Jillian Neal; Solomon Conteh; Liam Donnelly; Jingyang Chen; Kennan Marsh; Lynn Lambert; Sachy Orr-Gonzalez; Jessica Hinderer; Sara Healy; William Borkowsky; Scott R Penzak; Sumana Chakravarty; Stephen L Hoffman; Patrick E Duffy
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

7.  Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates.

Authors:  Charlotte V Hobbs; Saurabh Dixit; Scott R Penzak; Tejram Sahu; Sachy Orr-Gonzalez; Lynn Lambert; Katie Zeleski; Jingyang Chen; Jillian Neal; William Borkowsky; Yimin Wu; Patrick E Duffy
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

8.  Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study.

Authors:  Dina Creemers-Schild; Frank P Kroon; Ed J Kuijper; Mark G J de Boer
Journal:  Infection       Date:  2015-10-15       Impact factor: 3.553
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.